Gilero, a medical device manufacturer with two sites in North Carolina, is expanding to a third site in the state -- a new 60 ...

Reflect on your last visit to a healthcare provider. Did you feel like a valued partner in your care? Now, consider participating in a research study with an unapproved potential treatment. How has ...

Are you a small business owner or entrepreneur eager to strengthen your team and retain top talent? Join Innovate Carolina Junction on November 13 for an insightful workshop on employee retention ...

As algae blooms fed by chemical fertilizer runoff from farms and lawns contaminate more waterways every year, a North Carolina company is rooting its future in high-end eco-sensitive plant-growing ...

Enhancing soil health is “one of those rare win-win situations,” Wayne Honeycutt, president and CEO of the Morrisville, NC-based Soil Health Institute told the 2018 Ag Biotech Summit. “It’s good for ...

North Carolina is a global leader in gene therapy thanks to its renowned life science workforce development programs and the scientific output of its research universities. For example, Pfizer’s first ...

Jennifer Byrne wants to take some of the error out of trials. Clinical trials, that is. As the co-founder, CEO and board chair of Javara Inc., a privately funded ...

More than a decade ago, University of North Carolina at Chapel Hill scientist Anne Taylor, Ph.D., then a bioengineering graduate student at the University of California at Irvine, determined she ...

The first-ever point-of-care instrument for qualitatively detecting fentanyl in human urine has been cleared for use by the U.S. Food Drug Administration and will be distributed in the United States ...

Asklepios BioPharmaceutical (AskBio), a gene therapy platform company based in Chapel Hill, has spun out its fourth company, Actus Therapeutics, to develop gene therapies for rare genetic diseases ...

Rendering shows courtyard view of Syngenta complex with $94 million R&D and office expansion. CLICK ON THE PHOTO FOR MORE IMAGES OF THE PROJECT. Photo courtesy of Syngenta Biotechnology. Just two ...